Yap, T. A., Vieito Villar, M., Sepúlveda, J. M., Kondo, S., Simonelli, M., & Baldini, C. (2021). First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer.
Citação norma ChicagoYap, Timothy A., Maria Vieito Villar, Juan Manuel Sepúlveda, Shunsuke Kondo, Matteo Simonelli, e Capucine Baldini. First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients With Advanced Cancer. 2021.
Citação norma MLAYap, Timothy A., et al. First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients With Advanced Cancer. 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.